Form 8-K - Current report:
SEC Accession No. 0001193125-25-078604
Filing Date
2025-04-11
Accepted
2025-04-11 09:00:33
Documents
19
Period of Report
2025-04-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d836626d8k.htm   iXBRL 8-K 26852
2 EX-99.1 d836626dex991.htm EX-99.1 17243
7 GRAPHIC g836626g0411050314397.jpg GRAPHIC 5594
8 GRAPHIC g836626g0411050314600.jpg GRAPHIC 846
9 GRAPHIC g836626g0411050314699.jpg GRAPHIC 861
10 GRAPHIC g836626g0411050314792.jpg GRAPHIC 982
  Complete submission text file 0001193125-25-078604.txt   221623

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20250411.xsd EX-101.SCH 3911
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20250411_def.xml EX-101.DEF 13701
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20250411_lab.xml EX-101.LAB 22563
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20250411_pre.xml EX-101.PRE 14670
22 EXTRACTED XBRL INSTANCE DOCUMENT d836626d8k_htm.xml XML 5686
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 25830166
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)